Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes
Millan, Mark J, Maiofiss, Lisa, Cussac, Didier, Audinot, Valérie, Boutin, Jean-A, Newman-Tancredi, Adrian
Published in The Journal of pharmacology and experimental therapeutics (01.11.2002)
Published in The Journal of pharmacology and experimental therapeutics (01.11.2002)
Get full text
Journal Article
S18327 (1-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors: II. Functional Profile and a Multiparametric Comparison with Haloperidol, Clozapine, and 11 Other Antipsychotic Agents
Mark J. Millan, Mauricette Brocco, Jean-Michel Rivet, Valérie Audinot, Adrian Newman-Tancredi, Lisa Maiofiss, Sophie Queriaux, Nicole Despaux, Jean-Louis Peglion, Anne Dekeyne
Published in The Journal of pharmacology and experimental therapeutics (01.01.2000)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.01.2000)
Journal Article